Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
hearing loss
Biotech
Lilly snaps up hearing loss gene therapy player Akouos for $487M
The deal will give Lilly control of a treatment for a genetic form of hearing loss that is advancing toward a phase 1/2 trial.
Nick Paul Taylor
Oct 18, 2022 8:30am
Lucid launches new OTC hearing aids as FDA rule kicks in
Oct 17, 2022 10:30am
Otonomy's phase 2 backup plan fails, prompting new options
Oct 13, 2022 11:05am
Otonomy cuts lead asset loose after phase 2 failure to save cash
Aug 1, 2022 10:23am
Cochlear offers up $120M for Demant's hearing implant portfolio
Apr 28, 2022 1:10pm
Boehringer OKs $100M biobucks deal for hearing loss R&D project
Apr 13, 2022 8:00am
